Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Tellus Bioventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$41M
Portfolio companies 9
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.36
Key employees Soon

Areas of investment

  • Biotechnology
  • Biopharma
  • Health Care
  • Pharmaceutical
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Tellus Bioventures:
Typical Co-investors
Tellus Bioventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Tellus Bioventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BoostLAB -
China Environmental Fund Beijing, Beijing, China
EnCana Alberta, Calgary, Canada
Harrison Street Real Estate Capital Chicago, Illinois, United States
Horizons Labs -
Kaibang Ziben Beijing, Beijing, China
Nanjing Jiangbei New District Service Trade Innovation Development Fund China, Jiangsu, Nanjing
Orfin Ventures Bloomfield Hills, Michigan, United States
Ovctek China Anhui, China, Hefei
Quake Capital Partners Austin, Texas, United States
Royal Society Enterprise Fund England, London, United Kingdom
Saarbruecker 21 Berlin, Berlin, Germany
Schoffstall Ventures Harrisburg, Pennsylvania, United States
Stafford Capital Partners Boston, Massachusetts, United States
The R-Group, LLC Oregon, Portland, United States
Touchstone Ventures Central, Central Region, Singapore
Windcrest Partners New York, New York, United States
Wingtech Technology China, Shanghai
Woman Spark Ar Riyad, Riyadh, Saudi Arabia

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cantai Therapeutics

Life Science
Medical
$700K20 Nov 2023 -

Zenas BioPharma

Biopharma
Health Care
Pharmaceutical
$118M07 Nov 2022 -

Vittoria Biotherapeutics

Bioinformatics
Biotechnology
Test and Measurement
$10M07 Jun 2022 Philadelphia, Pennsylvania, United States

Dianthus Therapeutics

Biopharma
Biotechnology
Health Care
$100M19 Apr 2022 Waltham, Massachusetts, United States

Navrogen

Biotechnology
Life Science
Pharmaceutical
$3M09 Aug 2021 Philadelphia, Pennsylvania, United States

Interius BioTherapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
Therapeutics
$76M18 May 2021 Philadelphia, Pennsylvania, United States

Zenas BioPharma

Biopharma
Health Care
Pharmaceutical
23 Mar 2021 -

TamuroBio

Biotechnology
01 Jan 2021 Mclean, Virginia, United States

Aegle Therapeutics

Biotechnology
Clinical Trials
Therapeutics
$6M29 Sep 2020 Miami, Florida, United States
News
Navrogen Raises $3.0M in Seed Funding

– Navrogen, Inc. from Cheyney, Pa. raises $3.0M in equity financing.
– The financing was led by Tellus BioVentures along with existing investors.
– The company intends to use the funds to advance its Humoral Immuno-Oncology (HIO) discovery platform and preclinical therapeutic pipeline activities.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Tellus Bioventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 41M
Peak activity year 2021
Lead investments 1
Follow on index 0.36
Group Appearance index 0.79

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cantai Therapeutics

Life Science
Medical
$700K20 Nov 2023 -

Zenas BioPharma

Biopharma
Health Care
Pharmaceutical
$118M07 Nov 2022 -

Vittoria Biotherapeutics

Bioinformatics
Biotechnology
Test and Measurement
$10M07 Jun 2022 Philadelphia, Pennsylvania, United States

Dianthus Therapeutics

Biopharma
Biotechnology
Health Care
$100M19 Apr 2022 Waltham, Massachusetts, United States

Navrogen

Biotechnology
Life Science
Pharmaceutical
$3M09 Aug 2021 Philadelphia, Pennsylvania, United States

Interius BioTherapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
Therapeutics
$76M18 May 2021 Philadelphia, Pennsylvania, United States

Zenas BioPharma

Biopharma
Health Care
Pharmaceutical
23 Mar 2021 -

TamuroBio

Biotechnology
01 Jan 2021 Mclean, Virginia, United States

Aegle Therapeutics

Biotechnology
Clinical Trials
Therapeutics
$6M29 Sep 2020 Miami, Florida, United States
Crunchbase icon

Content report

The following text will be sent to our editors: